Colorado-based Enveda, which uses AI to discover new drugs in the natural world, raised a $311M Series E at a $2B valuation, double its valuation a year ago (Marina Temkin/TechCrunch)
Techmemeen
Marina Temkin / TechCrunch : Colorado-based Enveda, which uses AI to discover new drugs in the natural world, raised a $311M Series E at a $2B valuation, double its valuation a year ago — Enveda, a biotech startup that uses AI to discover new drugs in the natural world, has raised a $311 million Series E at a $2 billion valuation.
This is a short summary published by AI Global Wire. The full article is owned and hosted by Techmeme — open it there to read it in full.
Read the full story at Techmeme- Företag
Related AI news
- OpenAI and Anthropic bosses push UN for global terms on AIBBC Technology · September 23, 2026
- AI drug discovery startup Basecamp Research raises $140MSiliconANGLE · September 23, 2026
- Pilgrim, whose device combines air sampling and genomic sequencing to detect biological threats, raised a $25M seed led by Buckley at a $150M valuation (Kate Clark/Wall Street Journal)Techmeme · September 23, 2026
- Musk praises China’s leadership and pushes for AI regulation ahead of state dinnerMarketWatch Tech · September 23, 2026
- Nvidia-backed Nscale keeps its biggest customer, Bytedance, out of its IPO filingThe Decoder · September 23, 2026
- Magic AI raises £8m to take its AI-powered fitness mirror to the USSifted · September 23, 2026